BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21846291)

  • 1. Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.
    Chen Y; Fukuda T; Thakar MS; Kornblit BT; Storer BE; Santos EB; Storb R; Sandmaier BM
    Cytotherapy; 2011 Nov; 13(10):1269-80. PubMed ID: 21846291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.
    Zaucha JM; Zellmer E; Georges G; Little MT; Storb R; Storer B; Torok-Storb B
    Biol Blood Marrow Transplant; 2001; 7(11):613-9. PubMed ID: 11760149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological immunosuppression reduces but does not eliminate the need for total-body irradiation in nonmyeloablative conditioning regimens for hematopoietic cell transplantation.
    Mielcarek M; Torok-Storb B; Storb R
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1255-60. PubMed ID: 21220032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
    Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
    Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.
    Burroughs L; Mielcarek M; Little MT; Bridger G; Macfarland R; Fricker S; Labrecque J; Sandmaier BM; Storb R
    Blood; 2005 Dec; 106(12):4002-8. PubMed ID: 16105977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model.
    Sandmaier BM; Fukuda T; Gooley T; Yu C; Santos EB; Storb R
    Exp Hematol; 2003 Feb; 31(2):168-75. PubMed ID: 12591282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.
    Jochum C; Beste M; Zellmer E; Graves SS; Storb R
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):164-71. PubMed ID: 17241922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
    Storb R; Yu C; Wagner JL; Deeg HJ; Nash RA; Kiem HP; Leisenring W; Shulman H
    Blood; 1997 Apr; 89(8):3048-54. PubMed ID: 9108426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation.
    Kornblit B; Leisenring WM; Santos EB; Storb R; Sandmaier BM
    Chimerism; 2013; 4(3):95-101. PubMed ID: 23723082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.
    Storb R; Yu C; Zaucha JM; Deeg HJ; Georges G; Kiem HP; Nash RA; McSweeney PA; Wagner JL
    Blood; 1999 Oct; 94(7):2523-9. PubMed ID: 10498626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.
    Zaucha JM; Yu C; Zellmer E; Takatu A; Junghanss C; Little MT; Storb R
    Biol Blood Marrow Transplant; 2001; 7(9):513-6. PubMed ID: 11669218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors.
    Sandmaier BM; Storb R; Santos EB; Krizanac-Bengez L; Lian T; McSweeney PA; Yu C; Schuening FG; Deeg HJ; Graham T
    Blood; 1996 Apr; 87(8):3508-13. PubMed ID: 8605371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.
    Storb R; Yu C; Barnett T; Wagner JL; Deeg HJ; Nash RA; Kiem HP; McSweeney P; Seidel K; Georges G; Zaucha JM
    Blood; 1999 Aug; 94(3):1131-6. PubMed ID: 10419907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism.
    Li S; Thanikachalam M; Pang M; Carreno M; Aitouche A; Pham SM
    Exp Hematol; 2001 Apr; 29(4):534-41. PubMed ID: 11301194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig.
    Graves SS; Stone D; Loretz C; Peterson L; McCune JS; Mielcarek M; Storb R
    Transplantation; 2009 Aug; 88(3):317-22. PubMed ID: 19667932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.
    Chang J; Graves SS; Butts-Miwongtum T; Sale GE; Storb R; Mathes DW
    Transplantation; 2016 Dec; 100(12):e120-e127. PubMed ID: 27861292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
    Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
    Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
    Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
    J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.